IN2013CH01831A - - Google Patents
Download PDFInfo
- Publication number
- IN2013CH01831A IN2013CH01831A IN1831CH2013A IN2013CH01831A IN 2013CH01831 A IN2013CH01831 A IN 2013CH01831A IN 1831CH2013 A IN1831CH2013 A IN 1831CH2013A IN 2013CH01831 A IN2013CH01831 A IN 2013CH01831A
- Authority
- IN
- India
- Prior art keywords
- regadenoson
- group
- solvent selected
- mixture
- sulphoxide
- Prior art date
Links
Landscapes
- Saccharide Compounds (AREA)
Abstract
A process for the preparation of pure Regadenoson comprising; a. dissolving impure Regadenoson in a mixture of at least one solvent selected form the group consisting of amides, sulphoxide and at least one solvent selected from the group consisting of alcohol; b. treating the solution obtained in step(a) with one anti-solvent selected from the group comprising of nitriles, alcohols or mixture thereof; c. filtering the solid obtained in step (b) to attain pure Regadenoson; d. dissolving Regadenoson in at least one solvent selected from the group consisting of amides, sulphoxide or mixture thereof; e. treating the solution obtained in step (d) with co-solvent to get crystalline form of Regadenoson monohydrate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1831CH2013 IN2013CH01831A (en) | 2013-04-25 | 2013-04-25 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1831CH2013 IN2013CH01831A (en) | 2013-04-25 | 2013-04-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013CH01831A true IN2013CH01831A (en) | 2015-05-29 |
Family
ID=54394912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1831CH2013 IN2013CH01831A (en) | 2013-04-25 | 2013-04-25 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN2013CH01831A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10442832B2 (en) | 2015-02-06 | 2019-10-15 | Apicore Us Llc | Process of making regadenoson and novel polymorph thereof |
-
2013
- 2013-04-25 IN IN1831CH2013 patent/IN2013CH01831A/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10442832B2 (en) | 2015-02-06 | 2019-10-15 | Apicore Us Llc | Process of making regadenoson and novel polymorph thereof |
US11034714B2 (en) | 2015-02-06 | 2021-06-15 | Apicore Us Llc | Process of making regadenoson and novel polymorphs thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201691216A1 (en) | COMPOUNDS OF LINACLOTIDE WITH Slow Release | |
SG11201601363YA (en) | Process for purifying an acid composition comprising 2-formyl-furan-5-carboxylic acid and 2,5-furandicarboxylic acid | |
MX2016004406A (en) | 1,4-cyclohexylamine derivatives and processes for the preparation thereof. | |
MY196287A (en) | Methods For Purifying 5-(Halomethyl)Furfural | |
TW201613931A (en) | Form crystal of bisulfate of janus kinase (JAK) inhibitor and preparation method thereof | |
MX360957B (en) | Process of making adamantanamides. | |
WO2015037016A3 (en) | An improved process for the preparation of ticagrelor and intermediates thereof | |
MY166378A (en) | Zeoltic materials and methods for their preparation using alkenyltrialkylammonium compounds | |
BR112015022859A2 (en) | process for manufacturing gadofosveset trisodium monohydrate | |
NZ724923A (en) | Crystalline forms of grapiprant | |
WO2014141294A3 (en) | An improved process for the synthesis of melphalan and the hydrochloride salt | |
IN2014KN02722A (en) | ||
PH12015502486A1 (en) | N-(2-fluoro-2-phenethyl)carboxamides as nematicides and endoparasiticides | |
WO2015097717A3 (en) | AN IMPROVED PROCESS FOR THE PREPARATION OF β-CAROTENE | |
WO2015062937A3 (en) | Disperse dyes, their preparation and their use | |
WO2017093866A3 (en) | An improved process for the preparation of indigo carmine | |
IN2013CH01831A (en) | ||
WO2015087343A3 (en) | An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof | |
BR112016024977A2 (en) | process for the preparation of imidaclopride polymorphs | |
IN2013MU04056A (en) | ||
WO2012115402A3 (en) | Crystalline form of docetaxel and process for preparation thereof | |
IN2013MU03508A (en) | ||
MX2015017198A (en) | Matrix. | |
BR112015023591A2 (en) | Process for the preparation of 4-amino-1 - ((1s, 4r, 5s) -2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enii) -1h-pyrimidin-2-one | |
EP3438088A4 (en) | Crystals of novel hydroxamic acid derivative, method for producing same, and pharmaceutical composition |